Contribution of polycystic kidney disease to the development of chronic renal dysfunction in cats

Document Type : Original Article

Authors

1 Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Zabol, Zabol, Iran

2 Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran

Abstract
Polycystic kidney disease (PKD) is a hereditary disorder characterized by progressive renal cyst formation, leading to compromised kidney function and an increased risk of chronic kidney disease (CKD). This prospective, 18-month longitudinal study evaluated diagnostic and prognostic markers in 12 PKD-affected cats, utilizing ultrasound imaging alongside biochemical analysis. The study documented a 14.00% increase in cyst volume, a 7.00% enlargement in kidney length, and significant elevations in plasma creatinine, phosphorus, and blood urea nitrogen levels, underscoring their correlation with disease progression. Hematological analysis revealed progressive anemia associated with advanced CKD stages, further outlining the systemic impact of PKD. These findings emphasize the progressive nature of CKD in cats with PKD, despite diligent care provided by pet owners and veterinarians. Also, the importance of routine sonographic evaluation along with hematological and biochemical assessments is highlighted in our study to enhance early detection and improve outcomes in feline PKD. Future longitudinal studies with expanded cohorts are essential to validate these findings and refine diagnostic criteria for PKD-associated CKD.

Keywords

Subjects

1.     Bartges JW. Chronic kidney disease in dogs and cats. Vet Clin North Am Small Anim Pract 2012; 42(4): 669-692.
2.     Segev G, Cortellini S, Foster JD, et al. International Renal Interest Society best practice consensus guidelines for the diagnosis and management of acute kidney injury in cats and dogs. Vet J 2024; 305: 106068. doi: 10.1016/j.tvjl.2024.106068.
3.     Grauer GF. Early detection of renal damage and disease in dogs and cats. Vet Clin North Am Small Anim Pract 2005; 35(3): 581-596.
4.     Gendron K, Owczarek-Lipska M, Lang J, et al. Maine Coon renal screening: ultrasonographical characterisation and preliminary genetic analysis for common genes in cats with renal cysts. J Feline Med Surg 2013; 15(12): 1079-1085.
5.     Grantham JJ, Torres VE, Chapman AB, et al. Volume progression in polycystic kidney disease. N Engl J Med 2006; 354(20): 2122-2130.
6.     Tyson R, Logsdon SA, Werre SR, et al. Estimation of feline renal volume using computed tomography and ultrasound. Vet Radiol Ultrasound 2013; 54(2): 127-132.
7.     Yu Y, Shumway KL, Matheson JS, et al. Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model. BMC nephrol 2019; 20(1): 259. doi: 10.1186/s12882-019-1448-1.
8.     Burtis CA, Ashwood ER. Tietz textbook of clinical chemistry and molecular diagnosis. Section 2, Kidney function tests. 5th ed. St. Louis, USA: Elsevier 2012: 669-690.
9.     Morgan BR, Artiss JD, Zak B. Calcium determination in serum with stable alkaline Arsenazo III and triglyceride clearing. Clin Chem 1993; 39(8): 1608-1612.
10. Dumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. 1971. Clin Chim Acta 1997; 258(1): 21-30.
11. Weichselbaum TE. An accurate and rapid method for the determination of proteins in small amounts of blood serum and plasma. Am J Clin Pathol 1946; 10: 40-49.
12. Moss DW. Alkaline phosphatase isoenzymes. Clin Chem 1982; 28(10): 2007-2016.
13. Bae KT, Zhou W, Shen C, et al. Growth pattern of kidney cyst number and volume in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2019; 14(6): 823-833.
14. Wills SJ, Barrett EL, Barr FJ, et al. Evaluation of the repeatability of ultrasound scanning for detection of feline polycystic kidney disease. J Feline Med Surg 2009; 11(12): 993-996.
15. Vester U, Kranz B, Hoyer PF. The diagnostic value of ultrasound in cystic kidney diseases. Pediatr Nephrol 2010; 25(2): 231-240.
16. Grantham JJ, Torres VE. The importance of total kidney volume in evaluating progression of polycystic kidney disease. Nat Rev Nephrol 2016; 12(11): 667-677.
17. Noori Z, Moosavian H, Esmaeilzadeh H, et al. Prevalence of polycystic kidney disease in Persian and Persian related-cats referred to Small Animal Hospital, University of Tehran, Iran. Iran J Vet Res 2019; 20(2): 151-154.
18. Chakrabarti S, Syme HM, Elliott J. Clinicopathological variables predicting progression of azotemia in cats with chronic kidney disease. J Vet Intern Med 2012; 26(2): 275-281.
19. Kamal A. Estimation of blood urea (BUN) and serum creatinine level in patients of renal disorder. Indian J Fundam Appl Life Sci 2014; 4(4): 199-202.
20. Finch NC, Syme HM, Elliott J. Risk factors for development of chronic kidney disease in cats. J Vet Intern Med 2016; 30(2): 602-610.
21. Jiwaganont P, Jaturanratsamee K, Thaisakun S, et al. Analysis of serum proteomic in cats with polycystic kidney disease-1 gene mutation. Heliyon 2024;10(15): e35577. doi: 10.1016/j.heliyon.2024.e35577.
Volume 17, Issue 5
May 2026
Pages 353-359

  • Receive Date 09 December 2024
  • Revise Date 05 July 2025
  • Accept Date 10 December 2025